Exciting new research led by Dr. Kejal Kantarci, co-leader of the NAPS Neuroimaging Core, at Mayo Clinic.

Her study on FDG-PET brain imaging has uncovered crucial insights into brain metabolism changes during mild cognitive impairment.

NAPS members from McGill University, led by NAPS Co-Principal Investigator, Ron Postuma, have published a groundbreaking study in Brain journal!

NAPS Consortium Member Dr. Wolfgang Singer has been promoted to Professor of Neurology at the Mayo Clinic College of Medicine and Science.

Dr. Jeff Ratliff talks with Dr. Ron Postuma about the clinical features associated with IGLON5 positivity, emphasizing the implications for practitioners in diagnosing and treating sleep and movement disorders.

A recent publication from a large RBD cohort in Spain examined postmortem brain tissue from individuals who had RBD. This study showed there was abnormal synuclein in the cells that control atonia (muscle paralysis) during REM sleep in all the participants.

A recent study led by NAPS investigators Drs. Erik St. Louis and Brad Boeve from Mayo Clinic validated the use of an in-home sleep recording device to detect REM sleep without atonia.

The RBD Severity Scale, also known as the "IRBD-SSS" (International REM Sleep Behavior Disorder Study Group Symptom Severity Scale), is a tool used to assess the severity of REM Sleep Behavior Disorder (RBD) symptoms by evaluating the frequency and intensity of dream content, vocalizations, body movements, and potential injuries experienced by the patient, often with input from their bed partner as well.New research sheds light on REM sleep behavior disorder and its link to neurodegenerative diseases like Parkinson's. 🧠🔬💤

New research sheds light on REM sleep behavior disorder and its link to neurodegenerative diseases like Parkinson's. 🧠🔬💤

Researchers found that higher levels of belly and arm fat are associated with increased risk of developing Alzheimer's and Parkinson's diseases, especially among those with lower muscle strength. The study showed that individuals with high belly fat had a 13% higher risk, and those with high arm fat had an 18% higher risk of these neurodegenerative diseases compared to their counterparts with lower fat levels.

Recently, a study from Oregon Health & Science University showed that cerebrospinal fluid flows into the brain through distinct channels called perivascular spaces and then into the brain tissue, a discovery that aligns with the glymphatic system described in mice.

Memory loss is the most recognized symptom of dementia, particularly in Alzheimer's disease, but experts point out other early warning signs that are significant for types of dementia where forgetfulness isn't primary.

Here are five other common red flags to look out for.

We recently wrapped up our second Industry Roundtable at the Movement Disorders Society Congress in Philadelphia.

Our focus? Advancing clinical trials for neuroprotective treatments targeting synucleinopathies.

Wearable tech may help track non-motor Parkinson’s symptoms like sleep issues linked to REM sleep behavior disorder. NAPS will soon begin a pilot study at select sites.

A study suggests voice analysis in RBD patients may help detect early Parkinson’s progression. AI monitoring of voice, movement, and walking patterns shows promise but needs further validation.

The New York Times delves into the rise of sleep optimization, noting the risks of 'orthosomnia'—an excessive focus on perfect sleep that can backfire. While aids like magnesium and gadgets help some, experts emphasize simpler habits.

A study by Dr. Michael Howell and NAPS team at University of Minnesota found key differences between RBD triggered by antidepressants (Serotonergic RBD) and idiopathic RBD (iRBD). Follow-up ongoing to assess neurodegenerative risks.